Introduction to CV Pharmacology - Orlando Health
Introduction to CV Pharmacology - Orlando Health
Introduction to CV Pharmacology - Orlando Health
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>CV</strong> <strong>Pharmacology</strong><br />
Hydralazine<br />
Hydralazine has direct vasodila<strong>to</strong>ry effects on the vascular smooth muscle resulting in blood<br />
pressure lowering. It is one of the parenteral drugs of choice for management of pregnancyassociated<br />
hypertensive emergencies. However, other parenteral therapies (i.e., nitroprusside) are<br />
recommended for hypertensive crises in non-pregnant patients. When used parenterally,<br />
hydralazine is administered as intermittent doses. Hydralazine has been used in combination with<br />
isosorbide dinitrate as a second-line treatment of heart failure.<br />
Nesiritide (Natrecor)<br />
Nesiritide is a synthetic human B-type natriuretic peptide (BNP) with potent vasodila<strong>to</strong>r<br />
properties. Nesiritide binds <strong>to</strong> the recep<strong>to</strong>r sites of vascular smooth muscle resulting in an<br />
increase in cGMP, which is responsible for vasodilation of veins and arteries. It promotes<br />
diuresis and natruresis. It is currently indicated for the patient in acutely decompensated heart<br />
failure who is symp<strong>to</strong>matic with either minimal activity or dyspnea at rest.<br />
Precautions<br />
When B-type natriuretic peptide (BNP) lab values are ordered, the blood must be obtained prior<br />
<strong>to</strong> the administration of nesiritide (Natrecor). Since nesiritide (Natrecor) is a synthetic BNP, the<br />
lab results will be altered after this drug is administered.<br />
Due <strong>to</strong> its potent hypotensive properties, it is important <strong>to</strong> institute frequent blood pressure<br />
moni<strong>to</strong>ring. Review your institution’s policy regarding placement of the patient in an<br />
appropriate telemetry unit.<br />
© 2010 <strong>Orlando</strong> <strong>Health</strong>, Education & Development 31